CELESTICA INC

SEC filing reveals Celestica CEO’s long‑term stake, hinting at strategic focus on 7 nm nodes, supply‑chain resilience, and dual‑role hardware for edge‑AI and high‑performance servers.

CELESTICA INC drives biotech growth with solid earnings guidance, a strong product pipeline, and a low valuation, making it a compelling choice for investors.

Semiconductor ETFs keep growing amid tech‑index gains, showing investors confidence in chip supply chains and guiding IT leaders on smart allocations.

Celestica’s Q1 earnings and new AI‑chip partnerships show why it’s a top EMS choice for high‑performance AI hardware.

Investors shift >60 billion yuan from equities to bond‑type ETFs amid volatility, boosting fixed‑income AUM and reshaping portfolio strategies across sectors.

Munro’s Growth ETF spots CELESTICA, a precision‑engineering firm, in its 2026 holdings, highlighting the firm’s role in high‑performance materials for aerospace and automotive, and its potential to benefit from electrification and supply‑chain resil…

Celestica’s latest earnings show resilience amid AI‑driven demand, yet margin pressure and supply‑chain uncertainty pose risks. Discover how the company plans to navigate AI market shifts.

Celestica’s Q1 2026 earnings beat lifts guidance, yet shares dive as analysts flag valuation gaps, margin risks and heavy customer concentration—can the new DS6000‑series turn this skepticism into long‑term value?

Celestica’s Q1 2026 forecast shows a near‑tripled EPS and solid revenue growth driven by advanced HPC manufacturing, energy‑efficient design and supply‑chain resilience.

Celestica Inc. projects a 165% EPS jump and 44% revenue rise in Q4 2026, driven by high‑margin aerospace and digital‑twins tech, promising IT leaders new growth opportunities.